InvestorsHub Logo
Followers 114
Posts 6021
Boards Moderated 3
Alias Born 09/16/2009

Re: starbuxsux post# 2630

Tuesday, 02/25/2014 6:12:01 PM

Tuesday, February 25, 2014 6:12:01 PM

Post# of 3141
Wedbush starts at Outperform.

Wedbush's Liana Moussatos has started coverage on La Jolla Pharma (LJPC) with an Outperform and $27 PT.


Moussatos sees a "70% probability of a positive outcome" for a Phase 2a trial of La Jolla's GCS-100 drug in March, and thinks the drug could see peak annual sales of $1B.





http://seekingalpha.com/news/1591543-la-jolla-pharma-plus-22_4-percent-ah-wedbush-starts-at-outperform

Email: sheepery@gmail.com